Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FTO-stabilized miR-139–5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 16

Showing 16 citing articles:

Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health
Peipei Li, Yumeng Lin, Hongyun Ma, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 4
Recent advances in the reciprocal regulation of m6A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia
Jiawang Yang, Liang Feng, Fenglin Zhang, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108671-108671
Closed Access | Times Cited: 3
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
Jesús M. Pérez‐Gómez, Antonio J. Montero‐Hidalgo, Antonio C. Fuentes-Fayos, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1165-1187
Open Access | Times Cited: 9
Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus
P. J. Jayasree, Shalmoli Dutta, Pragati Karemore, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3042-3058
Closed Access | Times Cited: 8
Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K/Akt/mTOR signal pathway
Yujing Zhang, Yao Chen, Qiang Guo, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110072-110072
Closed Access | Times Cited: 2
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
Mehrdad Hashemi, Padideh Daneii, Mohammad Arad Zandieh, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 84-104
Open Access | Times Cited: 6
Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis
You Wu, Fenglin Zhang, Panling Xu, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 7, pp. 749-759
Closed Access | Times Cited: 1
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review)
Junjie Pan, Fei Tong, Ning Ren, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 1
What should be the future direction of development in the field of prostate cancer with lung metastasis?
Zhi‐Guang Huang, Yi Chen, Tong Wu, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 10, pp. 420-439
Open Access | Times Cited: 2
DNA damage-mediated FTO downregulation promotes CRPC progression by inhibiting FOXO3a via an m6A-dependent mechanism
Lele Xu, Yu‐Ting Chen, Tao Wu, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110505-110505
Open Access
The m6A regulators in prostate cancer: molecular basis and clinical perspective
Yu Cao, Man Jia, Chunyan Duan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
ZNF217 Mediates Transcriptional Activation of GRHL3 to Regulate SLC22A31 and Promote Malignant Progression in Thyroid Cancer
Ying Xu, Chunxu Liu, Qingrui Meng
Molecular Biotechnology (2024)
Closed Access
FTO in health and disease
Daniel Benák, Anna Ševčíková, Kristýna Holzerová, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Integrated analysis of the potential roles of microRNA-messenger RNA networks in prostate adenocarcinoma
Ningbo Zhang, Jian-jiang Jin, Xing-hong Ye
Heliyon (2023) Vol. 9, Iss. 12, pp. e22383-e22383
Open Access
Page 1

Scroll to top